News | October 13, 2023
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
The composition of ORAAL is protected by a granted patent in India until November 2033
The composition of ORAAL is protected by a granted patent in India until November 2033
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
India is promoting holistic healthcare with emphasis on preventive care
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The market capitalization of the company stood at Rs. 7,000 crore +
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Subscribe To Our Newsletter & Stay Updated
